Psychedelics have re-emerged in the world of medicine as a promising treatment for post traumatic stress disorder (PTSD), depression, substance use disorder (SUD), obsessive-compulsive disorder (OCD), headaches, chronic pain, and other conditions. Their potential for treating mental illness is exciting in particular for patients who have not gotten better from other standard treatments. Dr. Nina Vasan answers 5 questions about psychedelics that will help you understand what they are, how they work, and who may best benefit from them.
In recent years, there has been a surge of interest in microdosing, both from a research and a recreational perspective. More people have started using psychedelic microdoses not only to enhance their everyday functioning, but also as an attempt to self-medicate for various disorders. Some preliminary anecdotal evidence suggests that a large portion of microdosers are ADHD patients and some of them report being able to get adequate symptom relief, and even successfully replace their prescribed ADHD medication with microdoses.
Dr. Dave Rabin MD, PhD, a board-certified psychiatrist and neuroscientist that has spent his career studying resilience and helping people take control of their mental and physical health. He is currently working on one of the largest controlled studies of psychedelics to better understand how these medicines work to facilitate radically transformative healing experiences. In this session, Dr. Rabin discusses why psychedelics possess unprecedented potential to help individuals overcome trauma and chronic illnesses where traditional therapy, psychiatric care, and western medicine approaches may not be enough.
© Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details and accept the service to view the translations.